Literature DB >> 8557883

Changes in EEG power density of non-REM sleep in depressed patients during treatment with trazodone.

A L Van Bemmel1, D G Beersma, R H Van den Hoofdakker.   

Abstract

Recently, it was hypothesized that acute or cumulative suppression of non-REM sleep intensity might be related to the therapeutic effects of antidepressants. This intensity has been proposed to be expressed in the EEG power density in non-REM sleep. In the present study, the relationship was examined between the changes of EEG power density in non-REM sleep and the changes in clinical state in 8 depressed patients during treatment with trazodone. A 1-week wash-out period was followed by 1 week of placebo administration, a medication period of 5 weeks and a 1-week placebo period. To minimize systematic influences of sleep duration and non-REM-REM sleep alterations, EEG power was measured over the longest common amount of non-REM sleep stages 2-4 (168.5 min), accumulated from sleep onset onwards. During trazodone treatment, the 13- and 14-Hz bins showed a significant reduction in EEG power. No clear-cut change, however, was observed in the EEG power of the delta frequency range (1-4 Hz) which is considered to be the principle manifestation of non-REM sleep intensity. Furthermore, no overall significant relationship between EEG power suppression and clinical improvement could be demonstrated.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8557883     DOI: 10.1016/0165-0327(95)00033-j

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  3 in total

1.  Electroencephalographic power spectral density profile of the orexin receptor antagonist suvorexant in patients with primary insomnia and healthy subjects.

Authors:  Junshui Ma; Vladimir Svetnik; Ellen Snyder; Christopher Lines; Thomas Roth; W Joseph Herring
Journal:  Sleep       Date:  2014-10-01       Impact factor: 5.849

2.  Sleep-wake mechanisms and drug discovery: sleep EEG as a tool for the development of CNS-acting drugs.

Authors:  Luc Staner
Journal:  Dialogues Clin Neurosci       Date:  2002-12       Impact factor: 5.986

3.  Spectral EEG sleep profiles as a tool for prediction of clinical response to antidepressant treatment.

Authors:  Jean-Paul Macher; Rémy Luthringer; Luc Staner
Journal:  Dialogues Clin Neurosci       Date:  2004-03       Impact factor: 5.986

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.